Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review.
Tatevik BalayanHacsi HorvathGeorge W RutherfordPublished in: AIDS research and treatment (2017)
Initial ART regimens using DRV/r should be considered in future World Health Organization guidelines.